Retatrutide 5mg – About This Product
Retatrutide 5mg is a synthetic compound designed to activate multiple receptor systems: GIP, GLP-1, and glucagon. This retatrutide peptide is provided as a high-purity, lyophilized powder in a 5 mg vial, making it ideal for research purposes. It is primarily studied for its role in regulating metabolism, glucose control, and appetite. Retatrutide’s molecular structure allows for detailed studies into how multiple pathways work together to affect metabolism and energy balance.
Retatrutide 5mg Key Features and Benefits
- High purity (≥95%) for reliable research results.
- Supplied as a 5 mg vial with lyophilized powder, ensuring stable storage and easy reconstitution.
- Studied for its impact on metabolic and endocrine functions, especially glucose control and appetite regulation.
- Used in research on how GIP, GLP-1, and glucagon receptors work together.
- Manufactured under strict quality standards to ensure consistent results.
- Clearly labeled with traceability for researchers who wish to buy retatrutide for their studies.
Retatrutide 5mg Mechanism & Research Applications
Retatrutide is being researched for its ability to activate several hormone receptors involved in metabolism. By interacting with GIP, GLP-1, and glucagon receptors, it helps regulate appetite, glucose levels, and energy use.
Studies have focused on how these combined actions can impact metabolic markers, body composition, and nutrient use in controlled settings. This peptide is useful for understanding the interactions between multiple receptors and their role in metabolic processes.
Retatrutide 5mg Dosing & Observed Effects in Research
In research settings, retatrutide is typically studied at doses between 1 mg and 12 mg, usually given once a week through subcutaneous injections. Doses vary based on the study design and objectives. Clinical trials have shown effects on glucose tolerance, energy intake, and weight-related markers. These results are based on controlled studies, and findings should not be applied to clinical practice.
In Phase 2 and Phase 3 trials, retatrutide has demonstrated HbA1c reductions and weight loss, but these dosages are intended for clinical research only.
Retatrutide 5mg Storage, Safety & References
Store lyophilized retatrutide at –20°C or lower, away from light and moisture. After reconstitution, keep it at 2–8°C and use it within 5-7 days. To maintain stability, avoid multiple freeze-thaw cycles. Always handle the product using aseptic techniques and wear protective equipment (e.g., gloves and lab coats) when working with it. Dispose of any unused material according to safety guidelines.
References
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01053-X
https://www.sciencedirect.com/science/article/abs/pii/S0014299924007854
https://www.nature.com/articles/s41591-024-03018-2
https://pmc.ncbi.nlm.nih.gov/articles/PMC12190491
Compliance Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use.